Indomethacin Suppositories Suppliers & Bulk Manufacturers
Available Forms: Suppositories
Available Strengths: 25 mg, 50 mg
Reference Brands: Indocin(US & EU)
Category:
Analgesic
Indomethacin suppositories inhibit cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis responsible for pain and inflammation. Benefits include rapid, targeted relief for acute pain, especially for patients unable to take oral medications, with effective anti-inflammatory action and minimal systemic side effects when used appropriately.
Indomethacin Suppositories is available in Suppositories
and strengths such as 25 mg, 50 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Indomethacin Suppositories is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Indomethacin Suppositories can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Indomethacin suppositories are approved in the EU and US for short-term management of pain and inflammation, particularly in patients who cannot take oral medications. In the EU, they are regulated by EMA and require dossiers demonstrating safety, efficacy, and quality standards. In the US, FDA approval is based on extensive clinical data, with biosimilarity assessments and pharmacovigilance. Both regions require detailed dossiers for initial approval and continuous safety monitoring. For regulatory support, dossier preparation, and registration assistance, visit PharmaTradz. We ensure smooth market access for indomethacin suppositories, aligning with European and US regulatory standards for safe, effective anti-inflammatory therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing